Ckw Financial Group Astrazeneca PLC Transaction History

Ckw Financial Group

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$47.16 - $54.44 $28,295 - $32,664	-600 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$48.52 - $58.02 $14,556 - $17,406	-300 Reduced 33.33%	600 $30,000
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $31,842 - $36,660	-600 Reduced 40.0%	900 $49,000
Q2 2020 Aug 12, 2020	SELL	$43.1 - $55.31 $4,310 - $5,531	-100 Reduced 6.25%	1,500 $80,000
Q1 2020 May 12, 2020	SELL	$37.79 - $51.33 $22,674 - $30,798	-600 Reduced 27.27%	1,600 $70,000
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $25,476 - $30,276	-600 Reduced 21.43%	2,200 $110,000
Q4 2018 Jan 16, 2019	SELL	$36.86 - $41.49 $7,372 - $8,298	-200 Reduced 6.67%	2,800 $106,000
Q3 2017 Nov 13, 2017	BUY	$28.96 - $34.0 $86,880 - $102,000	3,000	3,000 $102,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ckw Financial Group, based on Form 13F filings with the SEC.

Stay updated on Ckw Financial Group with notifications on news.